Discussing Pfizer’s respiratory syncytial virus vaccine, Abrysvo

Scheduled for:May 30, 2023 8:00 PM EDT

Call Duration:30 minutes

Desired Expert

An infectiologist with experience in treating RSV.

Interview Goal

Getting an informed expert opinion on  Pfizer’s Abrysvo
for respiratory syncytial virus infections.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.